September 20, 2014 4:58 AM ET

Pharmaceuticals

Company Overview of Potentia Pharmaceuticals, Inc.

Executive Profile

Jason S. Slakter M.D.

Chief Medical Officer, Ohr Pharmaceutical, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 9 different industries.

See Board Relationships
----

Background

Dr. Jason S. Slakter, M.D. Co-Founded SKS Ocular, LLC in 2010 and serves as its Chief Executive Officer. Dr. Slakter has been Chief Medical Officer of Ohr Pharmaceutical, Inc. since June 2, 2014. Dr. Slakter serves as the Clinical Advisor of Acucela Inc. He serves as an Editor-in-Chief of Retinal Physician, is on the editorial board of Retina and serves as a scientific reviewer for major scientific ophthalmic journals. Dr. Slakter practices at the Vitreous-Retina-Macula ...

Corporate Headquarters

201 East Jefferson Street
Louisville, Kentucky 40202

United States

Phone: 502-569-1053
Fax: 502-569-1054

Board Members Memberships

There is no Board Members Memberships data available.

Education

There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Potentia Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.